iBio, Inc. (IBIO) Receives U.S. Patent Related to Fibrosis Treatment
Tweet Send to a Friend
iBio, Inc. (NYSE: IBIO) announced the issue by the U.S. Patent and Trademark Office on June 14, 201 of a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
